Earnings
Quarterly results explained in plain language, with reported figures versus expectations.
AbbVie Q3 2026 earnings: immunology drugs drive growth as guidance and dividend rise
ABBV · October 30, 2026AbbVie's Q3 2026 revenue rose about 10% on strong Skyrizi and Rinvoq sales, profit met expectations, and the company raised its full-year guidance and dividend.
Chevron Q3 2026 earnings: profit beats estimates on strong refining margins
CVX · October 30, 2026Chevron topped Wall Street's profit and revenue expectations in Q3 2026, helped by wide refining margins and higher output tied to last year's Hess acquisition.
LyondellBasell Q3 2026 earnings: narrow miss amid soft pricing, but cash flow improves
LYB · October 30, 2026LyondellBasell's Q3 2026 earnings and revenue came in slightly below estimates as product prices stayed soft, but cash generation and plant operations improved.
ExxonMobil Q3 2026 earnings: profit tops estimates on refining strength
XOM · October 30, 2026ExxonMobil's Q3 2026 adjusted profit and revenue beat Wall Street expectations, powered by record refining results and growing Guyana and Permian output, while the company raised its dividend and kept returning cash to shareholders.
Arthur J. Gallagher Q3 2026 earnings: revenue misses, adjusted profit holds steady
AJG · October 29, 2026Revenue fell short of Wall Street forecasts, but adjusted profit matched expectations, buoyed by acquisitions even as deal-related accounting charges weighed on reported earnings.
Amazon Q3 2026 earnings: AWS surges but profit and sales miss estimates
AMZN · October 29, 2026Amazon's cloud unit AWS grew at its fastest pace in nearly five years, but overall profit and sales missed Wall Street forecasts and shares fell.
Aon Q3 2026 earnings: revenue in line, adjusted profit up 10%
AON · October 29, 2026Aon posted revenue roughly in line with forecasts and 10% growth in adjusted profit per share in Q3 2026, with strong risk-advisory growth offset by a softer HR-consulting unit.
Bristol-Myers Squibb Q3 2026 earnings: sales beat estimates as newer drugs grow
BMY · October 29, 2026Bristol-Myers Squibb topped profit and sales forecasts in Q3 2026, driven by newer drugs and Eliquis, and nudged its full-year revenue outlook higher.
Caterpillar Q3 2026 earnings: profit tops estimates as AI power demand fuels record backlog
CAT · October 29, 2026Caterpillar's Q3 2026 profit edged past estimates on AI-driven demand for power equipment, even as revenue came in just shy of forecasts.
CRH PLC Q3 2026 earnings: results miss estimates, outlook trimmed
CRH · October 29, 2026CRH's Q3 2026 sales and profit missed Wall Street estimates as cost inflation and a weak housing market offset pricing gains, prompting the company to cut its full-year profit outlook.
D.R. Horton Q4 2026 earnings: profit falls short of estimates as incentives weigh on margins
DHI · October 29, 2026D.R. Horton's profit fell and missed Wall Street forecasts even as revenue topped estimates, as the homebuilder kept discounting to move houses amid soft buyer demand and gave a cautious fiscal 2027 outlook.
DaVita Q3 2026 earnings: profit tops estimates, but a China write-down clouds the beat
DVA · October 29, 2026DaVita beat revenue and profit estimates for Q3 2026, but a non-cash charge tied to its China business and a steep drop in free cash flow overshadowed the headline numbers.
Enterprise Products Partners Q3 2026 earnings: profit matches estimates, revenue tops forecasts
EPD · October 29, 2026Enterprise Products Partners posted Q3 2026 profit in line with estimates and revenue well above forecasts, with cash flow and distributions both climbing.
Gilead Sciences Q3 2026 earnings: HIV strength drives beat, guidance raised again
GILD · October 29, 2026Gilead topped Wall Street's revenue and adjusted-profit targets in Q3 2026 on strong HIV drug sales, and raised its full-year outlook for a fourth straight quarter.
Ingram Micro Q3 2026 earnings: record quarter tops estimates and guidance
INGM · October 29, 2026Ingram Micro's fiscal Q3 2026 sales and adjusted profit topped both Wall Street estimates and the company's own guidance, fueled by strong AI and cloud infrastructure demand.
Intel Q3 2026 earnings: AI-driven data center demand lifts profit as PC sales soften
INTC · October 29, 2026Intel's Q3 2026 profit and sales beat forecasts, fueled by booming AI and data-center chip demand, even as PC sales and foundry losses weighed on the picture.
Linde PLC Q3 2026 earnings: sales and profit beat estimates, outlook raised
LIN · October 29, 2026Linde's Q3 2026 sales and adjusted profit topped analyst estimates, and the company raised its full-year earnings outlook.
Eli Lilly Q3 2026 earnings: revenue jumps 39% on weight-loss drug demand
LLY · October 29, 2026Eli Lilly beat Q3 2026 profit and sales estimates as weight-loss and diabetes drug demand drove revenue up 39%, prompting another increase to its full-year outlook.
Mastercard Q3 2026 earnings: steady transaction growth keeps profits climbing
MA · October 29, 2026Mastercard's card network kept processing more global spending in Q3 2026, with profit growing faster than revenue as costs stay controlled and buybacks continue.
Mondelez Q3 2026 earnings: profit tops estimates as cocoa costs ease
MDLZ · October 29, 2026Mondelez's Q3 2026 adjusted profit beat estimates as easing cocoa costs lifted margins, even as revenue came in slightly below forecasts; full-year guidance held steady.